دورية أكاديمية
Rasburicase dose optimization for tumor lysis syndrome management in a network of community oncology practices.
| العنوان: | Rasburicase dose optimization for tumor lysis syndrome management in a network of community oncology practices. |
|---|---|
| المؤلفون: | Gilmore, Steven, Carroll, Melissa, Koselke, Elizabeth, Hough, Shannon |
| المصدر: | J Oncol Pharm Pract ; ISSN:1477-092X ; Volume:30 ; Issue:5 |
| بيانات النشر: | Atypon |
| سنة النشر: | 2024 |
| المجموعة: | PubMed Central (PMC) |
| مصطلحات موضوعية: | Rasburicase, costsaving, guideline, hyperuricemia, tumor lysis syndrome |
| الوصف: | Single, fixed-dose rasburicase administration has been evaluated as an effective strategy in the management of hyperuricemia in the hospital setting, but this has not yet been described within ambulatory community oncology practices. The objective of this study is to evaluate and optimize the dosing strategy for rasburicase in the management of tumor lysis syndrome (TLS)-associated hyperuricemia in The US Oncology Network (The Network). |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | https://doi.org/10.1177/10781552231190005Test; https://pubmed.ncbi.nlm.nih.gov/37563922Test |
| DOI: | 10.1177/10781552231190005 |
| الإتاحة: | https://doi.org/10.1177/10781552231190005Test https://pubmed.ncbi.nlm.nih.gov/37563922Test |
| رقم الانضمام: | edsbas.14E8A7B5 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1177/10781552231190005 |
|---|